Altimmune Inc (NASDAQ:ALT) shares, rose in value, with the stock price down by -4.03% to the previous day’s close as strong demand from buyers drove the stock to $5.72.
Actively observing the price movement in the last trading, the stock closed the session at $5.96. Referring to stock’s 52-week performance, its high was $11.77, and the low was $5.28. On the whole, ALT has fluctuated by -11.18% over the past month.
With the market capitalization of Altimmune Inc currently standing at about $440.52 million, investors are eagerly awaiting this quarter’s results, scheduled for in April.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 560.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ALT’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of ALT currently trading nearly -10.13% and -16.14% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 37.20, while the 7-day volatility ratio is showing 10.32% which for the 30-day chart, stands at 6.76%. Furthermore, Altimmune Inc (ALT)’s beta value is 0.80, and its average true range (ATR) is 0.46.
A comparison of Altimmune Inc (ALT) with its peers suggests the former has fared considerably weaker in the market. ALT showed an intraday change of -4.03% in last session, and over the past year, it shrunk by -52.69%%.
Data on historical trading for Altimmune Inc (NASDAQ:ALT) indicates that the trading volumes over the past 3 months, they’ve averaged 2.48 million. According to company’s latest data on outstanding shares, there are 77.01 million shares outstanding.
Nearly 1.03% of Altimmune Inc’s shares belong to company insiders and institutional investors own 53.07% of the company’s shares. The stock has fallen by -20.67% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ALT stock heading into the next quarter.
